About Us
ExCell Bio Group is a global leader in the life science reagents and bio-pharmaceutical critical materials industry, with over 20 years of experience. We are dedicated to providing high-quality cell culture media, serum products, and residue detection kits to customers in biopharmaceuticals, cell and gene therapy, stem cell research, and scientific institutions worldwide.
Our Culture
Our Mission
Accelerate the application of life science and technology to benefit the health of the people. We strive to bridge the gap between cutting-edge scientific discoveries and practical solutions, ensuring that advancements in life sciences can be rapidly translated into tangible benefits for global health.
Our Vision
To build a world-class and long-lasting enterprise in the fields of life sciences and biotechnology with independent intellectual property rights. We aim to not only lead the industry but also create a sustainable legacy, driving innovation and setting new benchmarks in the life sciences and biotechnology sectors.
Our Core Values
Customer First
Action with Vigor
Teamwork
Integrity and Professional Dedication
Passion and Innovation
Our Locations
Shanghai
Genetimes ExCell Technology, Inc.
Headquarters
5th Floor,Building 18,481 Guiping Road, Xuhui District,Shanghai
+86 0213 3676 611
Shanghai
Genetimes ExCell Technology, Inc.
Headquarters
5th Floor,Building 18,481 Guiping Road, Xuhui District,Shanghai
+86 0213 3676 611
Awards & Recognition
2013
It was established
In 2014
It won the titles of "Double Innovation Plan" talents, "Taicang Science and Technology Innovation Leading Talents" and "Gusu Innovation and Entrepreneurship Leading Talents"
In 2015
The Australian company was established
In 2016
The South American Uruguay company was put into production
In 2017
Won the "National high-tech Enterprise"
In 2018
The new R&D building in Taicang was completed and the serum-free culture medium project was launched
In 2019
Five serum-free culture-medium products with independent intellectual property rights and leading technology of Ecoxay were successively launched
Recognized as "Jiangsu Engineering Technology Research Center of Cell Therapy Medium and Gene Detection Reagent"
In 2020
The A round received nearly 100 million yuan of financing
Identified as "Engineering Research Center of CD-serum-free Medium for biopharmaceutical, cell therapy and other fields in Jiangsu Province"
In 2021
The large-scale GMP workshop of the medium was put into operation, and the B round of financing exceeded 100 million yuan
Won the title of "Provincial Enterprise Technology Center in 2021"
In 2022
The large-scale production workshop of identification reagents will be put into operation and the second production base in Uruguay will be expanded
Won the title of national specialized special new "little giant" enterprise
In 2023
Jiangsu Province and Suzhou City "unicorn" cultivation enterprises, Suzhou Management Quality Award winners;
Uruguay second serum factory completed, Shanghai R & D center completed
In 2024
Artica factory was included in the "Registration List of biological materials Enterprises for Bovine Blood and Blood Products imported to China" by China Customs.